Stay updated on Safety of DCC-2618 in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page.

Latest updates to the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- Revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no changes to study details, eligibility criteria, or user-visible content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAn in-page glossary control (Show glossary) is added to display definitions. The revision note updates to v3.4.0 with minor wording changes such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 on the page, indicating a small page update. No study content appears to be affected.SummaryDifference0.1%

- Check49 days agoChange DetectedNo significant changes detected between the two screenshots; the Study Details page content and layout appear unchanged.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Locations section has been added, listing the study sites by state (Arizona, California, Florida, Massachusetts, New York, Oregon, Pennsylvania, Texas, Utah, Virginia). The page also moves away from the old 'Arizona Locations' style headings and updates the revision to v3.3.3, while removing the HHS Vulnerability Disclosure entry.SummaryDifference0.9%

Stay in the know with updates to Safety of DCC-2618 in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page.